Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OLIVER, M. J.
Right arrow Articles by CHURCHILL, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OLIVER, M. J.
Right arrow Articles by CHURCHILL, D. N.
J Am Soc Nephrol 12:151-156, 2001
© 2001 American Society of Nephrology

Impact of Sodium and Ultrafiltration Profiling on Hemodialysis-Related Symptoms

MATTHEW J. OLIVER*, LLOYD J. EDWARDS{dagger} and DAVID N. CHURCHILL{ddagger}

* Sunnybrook & Women's College Health Sciences Centre, Toronto, Ontario, Canada
{dagger} School of Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
{ddagger} St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada.

Correspondence to Dr. Matthew J. Oliver, Sunnybrook & Women's College Health Sciences Centre, 2075 Bayview Avenue, Room A239, Toronto, Ontario M4N 3M5, Canada. Phone: 416-480-4755; Fax: 416-480-6940; E-mail: matthew.oliver{at}swchsc.on.ca

Abstract. Dialysate sodium and ultrafiltration profiling are two methods to reduce symptoms during hemodialysis. The objective of the study was to determine the efficacy of combining these techniques to reduce symptoms in chronic hemodialysis patients. Blood volume changes were measured to determine whether any benefit of profiling could be explained through this mechanism. Patients were randomized to profiled dialysate sodium and ultrafiltration or constant dialysate sodium and ultrafiltration. The study was a two-period, two-treatment, crossover design with repeated measures. The primary outcome was hypotension and/or symptomatic events observed by the dialysis nurse. Secondary outcomes were symptom survey scores, weights, BP, and blood volume changes. Thirty-three patients were randomized. On standard treatment, 30.6% of dialysis sessions were symptomatic compared with 20.4% on profiled treatments. The odds ratio for the development of hypotension or symptomatic event on profiled treatments was 0.61 (95% confidence interval, 0.39 to 0.96) compared with standard treatment. Patients had lower symptom scores by questionnaire in both the intradialytic and the interdialytic periods during profiled treatments. Predialysis weight was greater during profiled treatments by 0.3 kg (P = 0.008), but there were no differences in postdialysis weight, BP, or thirst. There was no difference in maximum decrease in blood volume during the two treatments (standard, -11.2%; profiled, -10.0%; P = 0.08), but there was a significant difference in the rate of change in blood volume (standard, -2.96%/h; profiled, -1.96%/h; P < 0.001). Decrease in blood volume, rate of change in blood volume, and predialysis weights were not associated with hypotension or symptomatic dialysis sessions. In conclusion, dialysate sodium and ultrafiltration profiling significantly reduces hemodialysis-related symptoms. Profiling reduces the slope of the blood volume curve during dialysis, but blood volume changes are not predictive of symptomatic events for an individual patient.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
H. Thein, I. Haloob, and M. R. Marshall
Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2630 - 2639.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. Mancini, E. Mambelli, M. Irpinia, D. Gabrielli, C. Cascone, F. Conte, G. Meneghel, F. Cavatorta, A. Antonelli, G. Villa, et al.
Prevention of dialysis hypotension episodes using fuzzy logic control system
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1420 - 1427.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. G. Narins, Participants:, M. Halperin, G. Danovitch, R. Falk, and J. Bargman
The Nephrology Quiz and Questionnaire: 2005
Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 592 - 608.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Moret, J. Aalten, W. van den Wall Bake, P. Gerlag, C. Beerenhout, F. van der Sande, K. Leunissen, and J. Kooman
The effect of sodium profiling and feedback technologies on plasma conductivity and ionic mass balance: a study in hypotension-prone dialysis patients
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 138 - 144.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. J. Dasselaar, R. M. Huisman, P. E. de Jong, and C. F. M. Franssen
Measurement of relative blood volume changes during haemodialysis: merits and limitations
Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2043 - 2049.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Locatelli, A. Covic, C. Chazot, K. Leunissen, J. Luno, and M. Yaqoob
Optimal composition of the dialysate, with emphasis on its influence on blood pressure
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 785 - 796.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Franssen, J. Dasselaar, and R. Huisman
Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume?
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 1010 - 1011.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. A. Knoll, J. A. Grabowski, G. F. Dervin, and K. O'Rourke
A Randomized, Controlled Trial of Albumin versus Saline for the Treatment of Intradialytic Hypotension
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 487 - 492.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Tisler, K. Akocsi, B. Borbas, L. Fazakas, S. Ferenczi, S. Gorogh, I. Kulcsar, L. Nagy, J. Samik, J. Szegedi, et al.
The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis
Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2601 - 2605.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. de Simone
Left Ventricular Geometry and Hypotension in End-Stage Renal Disease: A Mechanical Perspective
J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2421 - 2427.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP